Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: A pilot study
Open Access
- 1 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 12 (9) , 1357-1364
Abstract
Early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT) causes marked morbidity and mortality. We conducted a prospective pilot study to assess the safety and efficacy of molecular adsorbent recirculating system (MARS) in treatment of EAD after OLT. Twelve consecutive adult liver allograft recipients with a median age of 48 years, 9 of whom were male, were prospectively included and supported with MARS. EAD was defined as the presence of at least 2 of the following: serum bilirubin >10 mg/dL, prothrombin time 1,000 U/L, and plasma disappearance rate of indocyanine green (PDRICG) P = 0.002), serum creatinine (P = 0.006), and aspartate aminotransferase (P = 0.005) and a significant increase in PDRICG (P = 0.007) after MARS treatment. Prothrombin time, albumin level, and platelet count remained stable. Sustained improvement of renal and neurological function and of mean arterial pressure were observed. No MARS-related adverse effects occurred. MARS treatment provides a safe approach to the treatment of EAD after OLT. On the basis of this pilot study, a multicenter randomized clinical trial that uses MARS treatment in EAD after OLT has been initiated. Liver Transpl 12:1357-1364, 2006. © 2006 AASLD.Keywords
This publication has 24 references indexed in Scilit:
- Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its managementLiver Transplantation, 2004
- Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trialLiver Transplantation, 2003
- Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled studyHepatology, 2002
- Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failureLiver Transplantation, 2001
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantationTransplant International, 2000
- EARLY ALLOGRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATIONTransplantation, 1998
- Indocyanine Green Elimination Test in Orthotopic Liver RecipientsHepatology, 1996
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- A PILOT STUDY OF INDOCYANINE GREEN CLEARANCE AS AN EARLY PREDICTOR OF GRAFT FUNCTIONTransplantation, 1994